Chemically modified mRNA beyond COVID-19: Potential preventive and therapeutic applications for targeting chronic diseases

Chemically modified mRNA represents a unique, efficient, and straightforward approach to produce a class of biopharmaceutical agents. It has been already approved as a vaccination-based method for targeting SARS-CoV-2 virus. The COVID-19 pandemic has highlighted the prospect of synthetic modified mR...

Descripción completa

Detalles Bibliográficos
Autores principales: Elkhalifa, Dana, Rayan, Menatallah, Negmeldin, Ahmed T., Elhissi, Abdelbary, Khalil, Ashraf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Masson SAS. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552589/
https://www.ncbi.nlm.nih.gov/pubmed/34915673
http://dx.doi.org/10.1016/j.biopha.2021.112385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552589/
https://www.ncbi.nlm.nih.gov/pubmed/34915673
http://dx.doi.org/10.1016/j.biopha.2021.112385

Ejemplares similares